For further validation, an RNA immunoprecipitation (RIP) assay using an anti‐IGF2BP3 antibody was performed on PSCs treated with EVs from pancreatic cancer cells. This evidence concerns the gene IGF2BP3 and familial pancreatic carcinoma.